Updated
Updated · The Standard · Aug 17
CEMA Presents 3 HIV Treatment Studies at 26th AIDS Conference
Updated
Updated · The Standard · Aug 17

CEMA Presents 3 HIV Treatment Studies at 26th AIDS Conference

3 articles · Updated · The Standard · Aug 17

Summary

  • Three studies from the University of Nairobi's CEMA were presented at the 26th International AIDS Conference in Rio de Janeiro, highlighting promising HIV treatment options.
  • The research targets key evidence gaps in HIV care, including how to safely simplify treatment for ageing patients and what to do when resistance to HIV medicines emerges.
  • CEMA also presented findings on protecting mothers and children, extending the focus beyond long-term adult treatment management.
  • The conference presentations position the studies as part of a broader push to refine HIV care for populations facing increasingly complex treatment needs.

Insights

Could simplifying HIV treatments for older adults inadvertently trigger a new wave of untreatable, drug-resistant viral strains?
Why are non-integrase mutations silently threatening the lives of infants born to HIV-positive mothers despite modern therapies?
As long-acting HIV drugs become the norm, are we unknowingly accelerating the evolution of unstoppable super-viruses?